Bringing The Next-Generation Of Antibiotics
to win the war against resistant bacteria
Omnix Medical is a biopharmaceutical company
Founded in 2015, Omnix Medical is developing an arsenal of novel antibiotic agents for the treatment of infections involving drug-resistant bacteria.
Omnix’s technology can tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.
Our exceptional technology offers a first-in-its-class drug
Moving together towards a better future
MOVING TOGETHER TOWARDS A BETTER FUTURE
WE AT OMNIX MEDICAL
ARE ALWAYS LOOKING FOR EXTRAORDINARY PEOPLE TO JOIN OUR TEAM
New antimicrobial agents are urgently needed, especially to eliminate multidrug resistant Gram‐ negative bacteria that stand for most antibiotic‐resistant threats. In the following study, we
Une nouvelle technologie inspirée par la nature pour éradiquer de dangereuses bactéries multirésistantes. (A new technology inspired by nature to eradicate dangerous multiresistant bacteria.)
Omnix Medical, a Jerusalem-based biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, has been awarded €10.8 million in EU funding under the EIC Accelerator Programme.